Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Establishing a comprehensive questionnaire for detecting drug-induced extrapyramidal symptoms.

Ohno K, Miyazawa S, Hashiguchi M, Unemoto T, Itoh A, Echizen H, Rikihisa T, Ogata H, Murata M.

Yakugaku Zasshi. 2003 Oct;123(10):881-6.

2.

[Drug use evaluation of antidyslipidemic agents at a community hospital in Japan].

Ujita K, Ohno K, Hashiguchi M, Echizen H, Rikihisa T, Ogata H.

Yakugaku Zasshi. 2002 Jul;122(7):499-506. Japanese.

3.

A simplified method for detecting isoniazid compliance in patients receiving antituberculosis chemotherapy.

Hashiguchi M, Ohno K, Sakuma A, Hino F, Tanaka T, Ohtsuji M, Matsumoto N, Yanase K, Urae A, Hosogai Y, Sato N, Yazaki A, Matsuda K, Yamazaki K, Rikihisa T.

J Clin Pharmacol. 2002 Feb;42(2):151-6.

PMID:
11831537
4.

[No relation between angiotensin-converting enzyme (ACE) inhibitor-induced cough and ACE gene polymorphism, plasma bradykinin, substance P and ACE inhibitor concentration in Japanese patients].

Okumura H, Nishimura E, Kariya S, Ohtani M, Uchino K, Fukatsu T, Odanaka J, Takahashi T, Watanabe K, Itoh T, Hashiguchi M, Echizen H, Rikihisa T.

Yakugaku Zasshi. 2001 Mar;121(3):253-7. Japanese.

5.

Prevention of hepatitis C virus infection in a chimpanzee by vaccination and epitope mapping of antiserum directed against hypervariable region 1.

Goto J, Nishimura S, Esumi M, Makizumi K, Rikihisa T, Nishihara T, Mizuno K, Zhou Y, Shikata T, Fujiyama S, Tomita K.

Hepatol Res. 2001 Mar 26;19(3):270-283.

PMID:
11251310
6.

Effect of cimetidine and probenecid on pilsicainide renal clearance in humans.

Shiga T, Hashiguchi M, Urae A, Kasanuki H, Rikihisa T.

Clin Pharmacol Ther. 2000 Mar;67(3):222-8.

PMID:
10741624
7.
8.

Active oxygen species generation and cellular damage by additives of parenteral preparations: selenium and sulfhydryl compounds.

Terada A, Yoshida M, Seko Y, Kobayashi T, Yoshida K, Nakada M, Nakada K, Echizen H, Ogata H, Rikihisa T.

Nutrition. 1999 Sep;15(9):651-5.

PMID:
10467607
9.

Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees.

Esumi M, Rikihisa T, Nishimura S, Goto J, Mizuno K, Zhou YH, Shikata T.

Arch Virol. 1999;144(5):973-80.

PMID:
10416378
10.

Correlation of in vivo infectivity of hepatitis C virus to in vitro infectivity and to virion properties.

Yoshikura H, Hijikata M, Nakajima N, Wang M, Mizuno K, Rikihisa T, Ueno T, Nishimura S, Shimizu Y.

Princess Takamatsu Symp. 1995;25:139-42.

PMID:
8875618
11.

Selective transmission of hepatitis C virus in vivo and in vitro.

Hijikata M, Mizuno K, Rikihisa T, Shimizu YK, Iwamoto A, Nakajima N, Yoshikura H.

Arch Virol. 1995;140(9):1623-8.

PMID:
7487493
12.

Possible occurrence of P450 related to P450 HFLb in extrahepatic tissues of human fetuses and its contribution to metabolic activation of promutagens.

Kato T, Nakasa H, Ohmori S, Kamataki T, Itahashi K, Shimada T, Rikihisa T, Kitada M.

Mutat Res. 1994 Oct 1;310(1):73-7.

PMID:
7523886
13.

Immunochemical evidence for the occurrence of Mu class glutathione S-transferase in human fetal livers.

Mera N, Ohmori S, Itahashi K, Kiuchi M, Igarashi T, Rikihisa T, Kitada M.

J Biochem. 1994 Aug;116(2):315-20.

14.

Rat liver microsomal cytochrome P-450 responsible for reductive metabolism of zonisamide.

Nakasa H, Komiya M, Ohmori S, Rikihisa T, Kitada M.

Drug Metab Dispos. 1993 Sep-Oct;21(5):777-81.

PMID:
7902235
15.

Characterization of human liver microsomal cytochrome P450 involved in the reductive metabolism of zonisamide.

Nakasa H, Komiya M, Ohmori S, Rikihisa T, Kiuchi M, Kitada M.

Mol Pharmacol. 1993 Jul;44(1):216-21.

PMID:
8341274
16.

Studies on cytochrome P450 responsible for oxidative metabolism of imipramine in human liver microsomes.

Ohmori S, Takeda S, Rikihisa T, Kiuchi M, Kanakubo Y, Kitada M.

Biol Pharm Bull. 1993 Jun;16(6):571-5.

PMID:
8364509
17.

Species differences of testosterone 16-hydroxylases in liver microsomes of guinea pig, rat and dog.

Ohmori S, Taniguchi T, Rikihisa T, Kanakubo Y, Kitada M.

Xenobiotica. 1993 Apr;23(4):419-26.

PMID:
8337900
18.

An epidemic outbreak of hepatitis E in Yangon of Myanmar: antibody assay and animal transmission of the virus.

Uchida T, Aye TT, Ma X, Iida F, Shikata T, Ichikawa M, Rikihisa T, Win KM.

Acta Pathol Jpn. 1993 Mar;43(3):94-8.

PMID:
8257479
19.

Effects of clarithromycin and its metabolites on the mixed function oxidase system in hepatic microsomes of rats.

Ohmori S, Ishii I, Kuriya S, Taniguchi T, Rikihisa T, Hirose S, Kanakubo Y, Kitada M.

Drug Metab Dispos. 1993 Mar-Apr;21(2):358-63.

PMID:
8097709
20.

Sequence and gene structure of the hepatitis E virus isolated from Myanmar.

Aye TT, Uchida T, Ma X, Iida F, Shikata T, Ichikawa M, Rikihisa T, Win KM.

Virus Genes. 1993 Feb;7(1):95-109.

PMID:
8470371
21.

Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.

Ohmori S, Shirakawa C, Motohashi K, Yoshida H, Abe H, Nakamura T, Horie T, Kitagawa H, Asaoka K, Rikihisa T, et al.

Mol Pharmacol. 1993 Feb;43(2):183-90.

PMID:
8429823
22.

Immunochemical characterization and toxicological significance of P-450HFLb purified from human fetal livers.

Kitada M, Kato T, Ohmori S, Kamataki T, Itahashi K, Guengerich FP, Rikihisa T, Kanakubo Y.

Biochim Biophys Acta. 1992 Oct 27;1117(3):301-5.

PMID:
1420280
23.

Formation of reductive metabolite, 2-sulfamoylacetylphenol, from zonisamide in rat liver microsomes.

Nakasa H, Komiya M, Ohmori S, Kitada M, Rikihisa T, Kanakubo Y.

Res Commun Chem Pathol Pharmacol. 1992 Jul;77(1):31-41.

PMID:
1439179
24.

Hepatitis E virus: cDNA cloning and expression.

Uchida T, Suzuki K, Hayashi N, Iida F, Hara T, Oo SS, Wang CK, Shikata T, Ichikawa M, Rikihisa T, et al.

Microbiol Immunol. 1992;36(1):67-79.

25.

[Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].

Nomura F, Ohnishi K, Ohto M, Takeda Y, Rikihisa T, Kanakubo Y.

Rinsho Byori. 1991 Oct;39(10):1093-7. Japanese.

PMID:
1762184
26.

Animal model, virology and gene cloning of hepatitis E.

Uchida T, Suzuki K, Iida F, Shikata T, Ichikawa M, Rikihisa T, Mizuno K, Win KM.

Gastroenterol Jpn. 1991 Jul;26 Suppl 3:148-51.

PMID:
1909255
27.

Decrease in the specific forms of cytochrome P-450 in liver microsomes of a mutant strain of rat with hyperbilirubinuria.

Ohmori S, Kuriya S, Uesugi T, Horie T, Sagami F, Mikami T, Kawaguchi A, Rikihisa T, Kanakubo Y.

Res Commun Chem Pathol Pharmacol. 1991 May;72(2):243-53.

PMID:
1876754
28.

Cloning and expression of cDNAs from enterically-transmitted non-A, non-B hepatitis virus.

Ichikawa M, Araki M, Rikihisa T, Uchida T, Shikata T, Mizuno K.

Microbiol Immunol. 1991;35(7):535-43.

29.

Occurrence and character of a putative causative virus of enterically-transmitted non-A, non-B hepatitis in bile.

Uchida T, Suzuki K, Komatsu K, Iida F, Shikata T, Rikihisa T, Mizuno K, Soe S, Win KM, Nakane K.

Jpn J Exp Med. 1990 Feb;60(1):23-9.

PMID:
2112653
30.

Serial transmission of a putative causative virus of enterically transmitted non-A, non-B hepatitis to Macaca fascicularis and Macaca mulatta.

Uchida T, Win KM, Suzuki K, Komatsu K, Iida F, Shikata T, Rikihisa T, Mizuno K, Soe S, Myint H, et al.

Jpn J Exp Med. 1990 Feb;60(1):13-21.

PMID:
2112652
31.

Enterically transmitted non-A, non-B hepatitis in cynomolgus monkeys: morphology and probable mechanism of hepatocellular necrosis.

Soe S, Uchida T, Suzuki K, Komatsu K, Azumi J, Okuda Y, Iida F, Shikata T, Rikihisa T, Mizuno K, et al.

Liver. 1989 Jun;9(3):135-45.

PMID:
2501612
32.

[Epidemic non-A, non-B viral hepatitis--animal model and causative virus].

Uchida T, Soe S, Suzuki K, Komatsu K, Shikata T, Iida F, Rikihisa T, Mizuno K.

Nihon Rinsho. 1988 Dec;46(12):2589-95. Japanese. No abstract available.

PMID:
3149331
33.

The proteins immunochemically related to P-450 HFLa, a major form of cytochrome P-450 in human fetal livers, are present in liver microsomes from various animal species.

Kitada M, Igoshi N, Kamataki T, Itahashi K, Rikihisa T, Kanakubo Y.

Res Commun Chem Pathol Pharmacol. 1988 Oct;62(1):31-40.

PMID:
3144721
34.

Immunochemical similarity of P-450 HFLa, a form of cytochrome P-450 in human fetal livers, to a form of rat liver cytochrome P-450 inducible by macrolide antibiotics.

Kitada M, Igoshi N, Kamataki T, Itahashi K, Imaoka S, Komori M, Funae Y, Rikihisa T, Kanakubo Y.

Arch Biochem Biophys. 1988 Jul;264(1):61-6.

PMID:
3395131
35.

P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16 alpha-hydroxylase of dehydroepiandrosterone 3-sulfate.

Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kanakubo Y.

J Biol Chem. 1987 Oct 5;262(28):13534-7.

36.

Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations.

Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kanakubo Y.

Biochem Pharmacol. 1987 Feb 15;36(4):453-6.

PMID:
3493777
37.

Effects of cytochrome b5 on aniline hydroxylation catalyzed by a reconstituted system containing acetone or 2,2'-bipyridine.

Kitada M, Yamaguchi N, Rikihisa T, Kanakubo Y, Kitagawa H.

Jpn J Pharmacol. 1986 Feb;40(2):347-9.

38.

Enhancement of aniline hydroxylation in human liver microsomes.

Kitada M, Hasunuma Y, Rikihisa T, Kanakubo Y.

Res Commun Chem Pathol Pharmacol. 1986 Jan;51(1):101-16.

PMID:
3081974
39.

Immunochemical examinations of cytochrome P-450 in various tissues of human fetuses using antibodies to human fetal cytochrome P-450, P-450 HFLa.

Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kato R, Kanakubo Y.

Biochem Biophys Res Commun. 1985 Sep 30;131(3):1154-9.

PMID:
4052083
40.

Purification and properties of cytochrome P-450 from homogenates of human fetal livers.

Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kato R, Kanakubo Y.

Arch Biochem Biophys. 1985 Aug 15;241(1):275-80.

PMID:
4026319
41.
42.
43.

New approach to the hepatic first-pass effect by whole-body autoradiography.

Rikihisa T, Ohkuma T, Mori M, Otsuka M, Suzuki T.

Chem Pharm Bull (Tokyo). 1981 Jul;29(7):2035-42. No abstract available.

PMID:
7307199
44.

Influence of the route of administration on the mean hepatic extraction ratio of propranolol in the rat.

Suzuki T, Isozaki S, Ohkuma T, Rikihisa T.

J Pharmacobiodyn. 1980 Nov;3(11):603-11.

PMID:
7241334
45.

Studies on absorption, distribution, metabolism and excretion of bunitrolol, a beta-adrenergic blocking agent, in rats and mice.

Suzuki T, Rikihisa T.

Arzneimittelforschung. 1979;29(11):1707-15. No abstract available.

PMID:
44473
46.
47.

[A new method for making thyroglobulin sensitized cell using diamino-diphenyl-sulfone (DDS) (author's transl)].

Kato R, Noguchi S, Rikihisa T, Kaku A, Otomo N.

Rinsho Byori. 1978 Jul;26(7):619-22. Japanese. No abstract available.

PMID:
713099
48.

Improved method for sampling hepatic venous blood in the rat.

Suzuki T, Ohkuma T, Rikihisa T, Isozaki S.

J Pharm Sci. 1975 May;64(5):895-7. No abstract available.

PMID:
1151672
49.

Reaction of aromatic aldehydes with glyceraldehyde 3-phosphate dehydrogenase.

Fife TH, Rikihisa T, Benjamin BM.

Biochemistry. 1971 Oct 12;10(21):3875-80. No abstract available.

PMID:
5168563
50.

Reaction of glyceraldehyde 3-phosphate dehydrogenase with aliphatic aldehydes.

Fife TH, Rikihisa T.

Biochemistry. 1970 Oct 13;9(21):4064-7. No abstract available.

PMID:
5466415

Supplemental Content

Loading ...
Support Center